“…This was consistent with the range of categories and subcategories which were documented throughout the PROMISe II study [15,18]. The variation between the DRP classification systems in international literature again makes direct comparisons difficult; however, most studies show drug selection, drug-drug interactions (which are classified as a Drug selection or Toxicity issue in the DOCUMENT system, depending on whether symptoms have occurred) and dosage problems as the most common interventions [12,[19][20][21]. During the trial, the most common recommendations were a Counselling or education session for the patient and Referral to the prescriber.…”